News & Stories

News & Stories

Portfolio Company DEMECAN
Receives GMP-Certificate

The Dresden-based company DEMECAN managed to receive the GMP certificate from the Saxon state authority for its cannabis production facility.

Berlin/Dresden, January 18, 2022DEMECAN, currently the only independent German cannabis producer for medical applications, has received the manufacturing permit from the Saxon state authority for its Dresden production facility in accordance with Section 13 AMG and GMP (Good Manufacturing Practice) certification. The GMP certification allows DEMECAN to produce dried cannabis as a medicinal product.

“Due to the high quality expectations of medicines, the GMP certification is the most stringent standard that manufacturers have to meet. The fact that we now hold this certificate in our hands is an extraordinary milestone in the young history of DEMECAN and an important one for the development of the German cannabis center in Saxony.”

– Dr. Adrian Fischer – DEMECAN Managing Director

The certification, with international recognition, guarantees the quality requirements of medicinal products throughout the entire manufacturing process. GMP short for “Good Manufacturing Process”, stands for the highest manufacturing standards and the fact that the production is continuously controlled and independently monitored by pharmaceutical authorities.

“As the founder and managing director, I am very grateful for the great team with which we managed to pass the inspection just six weeks after the completion of our building. All this even though we have fully ramped up production capacity at the same time.”

– Dr. Adrian Fischer – DEMECAN Managing Director

Starting Q1/22, the company plans to sell their first cannabis flowers to German pharmacies, complementing their existing Florestura flower portfolio. The GMP certification now enables DEMECAN to produce its own medicines and to check their effectiveness based on clinical studies. Research in the medical cannabis field is important to verify the often-criticized benefits. DEMECAN wants to support this with its own resources and plans to start their first studies this year.


DEMECAN is the only independent company in Germany that covers the entire medical cannabis sales cycle – from production to processing, storage and distribution to pharmacies. The company founded in 2017 by Dr. Adrian Fisher, Dr. Cornelius Maurer and Dr. Constantin von der Groeben aims to guarantee patients access to high-quality medicinal cannabis. In May 2019, the company was the only German company to receive the surcharge for the cultivation and distribution of medical cannabis and is a member of the Federal Association of Pharmaceutical Cannabinoid Companies (BPC) and a supporting member of the Association of Cannabis Supplying Pharmacies (VCA e.V.).

More information: